Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets

被引:126
|
作者
Chen, Jing [1 ]
Wang, Rui [1 ]
Zhang, Kai [1 ]
Chen, Long-Bang [1 ]
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
long non-coding RNA; non-small cell lung cancer; biomarker; molecular target; EPITHELIAL-MESENCHYMAL TRANSITION; POOR-PROGNOSIS; BREAST-CANCER; UP-REGULATION; MEG3; GENE; EXPRESSION; CARCINOMA; MALAT-1; GROWTH;
D O I
10.1111/jcmm.12431
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lung cancer-associated mortality is the most common cause of cancer death worldwide. Non-coding RNAs (ncRNAs), with no protein-coding ability, have multiple biological roles. Long non-coding RNAs (lncRNAs) are a recently characterized class of ncRNAs that are over 200 nucleotides in length. Many lncRNAs have the ability of facilitating or inhibiting the development and progression of tumours, including non-small cell lung cancer (NSCLC). Because of their fundamental roles in regulating gene expression, along with their involvement in the biological mechanisms underlying tumourigenesis, they are a promising class of tissue- and/or blood-based cancer biomarkers. In this review, we highlight the emerging roles of lncRNAs in NSCLC, and discuss their potential clinical applications as diagnostic and prognostic markers and as therapeutic targets.
引用
收藏
页码:2425 / 2436
页数:12
相关论文
共 50 条
  • [11] Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma
    Qiu, Lipeng
    Tang, Qi
    Li, Guohui
    Chen, Keping
    LIFE SCIENCES, 2017, 191 : 273 - 282
  • [12] A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer
    Zhou, Meng
    Guo, Maoni
    He, Dongfeng
    Wang, Xiaojun
    Cui, Yinqiu
    Yang, Haixiu
    Hao, Dapeng
    Sun, Jie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [13] Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer
    Sun, Yan
    Ling, Chunhua
    MEDICINE, 2019, 98 (30)
  • [14] Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers
    Yang, Qing-Qing
    Deng, Yan-Fei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (04): : 1286 - 1292
  • [15] Long Non-coding RNAs and Their Roles in Non-small-cell Lung Cancer
    Ming-Ming Wei
    Guang-Biao Zhou
    Genomics,Proteomics & Bioinformatics, 2016, (05) : 280 - 288
  • [16] From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer
    Gutschner, Tony
    Richtig, Georg
    Haemmerle, Monika
    Pichler, Martin
    CANCER AND METASTASIS REVIEWS, 2018, 37 (01) : 83 - 105
  • [17] Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies
    Wang, Maolong
    Sun, Xiao
    Wang, Hao
    Xin, Yanlu
    Jiao, Wenjie
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (07) : 2636 - 2653
  • [18] Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer
    Lin, Shan
    Zhen, Yu
    Guan, Yinghui
    Yi, Huanfa
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4181 - 4191
  • [19] Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets
    Vercouillie, Niels
    Ren, Zhiyao
    Terras, Eva
    Lammens, Tim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [20] Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets
    Yang, Mei
    Hu, Xue
    Tang, Bin
    Deng, Fengmei
    HELIYON, 2024, 10 (02)